Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Lilly evaluates cardiovascular effects of Evista in RUTH trial

March 27, 1998

Bosentan reduces blood pressure in patients with essential hypertension

March 26, 1998

VEGF gene medicine incorporating DOTMA enters phase II testing

March 25, 1998

Spotlight on dual-action ACE/NEP inhibitors

March 25, 1998

Calcium channel blockers do not increase risk of cancer in patients with coronary artery disease

March 24, 1998

U. of Alberta researchers discover novel 1,4-dihydropyridine calcium channel modulators

March 20, 1998

Vitamin C prevents development of nitrate tolerance in CHF

March 20, 1998

Mochida describes PDE V inhibitors for pulmonary hypertension, ischemic heart disease

March 20, 1998

CytRx begins patient enrollment for Flocor phase III trial

March 19, 1998

LXR files IND for CP-Cardiosol

March 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...